Alwazzan, A. et al. 2026. Tumor Marker Heterogeneity in Ovarian Cancer: Clinical Implications of Pretreatment Monitoring of Serum Biomarkers for Recurrence Prediction. World Journal of Oncology. (Jul. 2026). DOI:https://doi.org/10.14740/wjon2800.